Eiken Chemical Co., Ltd. (TYO:4549)
2,173.00
-5.00 (-0.23%)
Feb 27, 2025, 3:30 PM JST
Eiken Chemical Revenue
Eiken Chemical had revenue of 10.91B JPY in the quarter ending December 31, 2024, with 6.67% growth. This brings the company's revenue in the last twelve months to 40.20B, up 0.74% year-over-year. In the fiscal year ending March 31, 2024, Eiken Chemical had annual revenue of 40.05B, down -7.44%.
Revenue (ttm)
40.20B
Revenue Growth
+0.74%
P/S Ratio
1.90
Revenue / Employee
53.10M
Employees
757
Market Cap
74.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
Mar 31, 2021 | 38.67B | 2.08B | 5.69% |
Mar 31, 2020 | 36.59B | 824.00M | 2.30% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |